INTCO Medical 2025 Earnings Report
Analysis based on 7 articles · First reported Apr 29, 2026 · Last updated Apr 29, 2026
The positive earnings report from INTCO Medical, showcasing resilient growth and strategic expansion, is likely to be viewed favorably by financial markets, potentially leading to increased investor confidence in INTCO Medical and the medical consumables sector. The company's global expansion and innovation investments suggest a strong outlook for future performance.
INTCO Medical, a leading global manufacturer of disposable gloves, reported its 2025 annual results, with revenue reaching RMB 9.93 billion (approximately US$1.46 billion), a four-year high, and net profit attributable to shareholders of RMB 1.01 billion (approximately US$148.03 million). The company's annualized production capacity for disposable non-latex gloves reached 103 billion pieces. INTCO Medical maintained stable operations amid industry rebalancing, with gross margin rising and net cash flow from operating activities increasing significantly. The company expanded its overseas production capacity, including new facilities in Vietnam, and continued to invest heavily in research and development, reaching RMB 404 million. INTCO Medical also deepened its global market network, serving over 15,000 customers across more than 150 countries and regions, with marketing and service centers in the United States, Canada, Germany, Japan, Malaysia, Singapore, and China — Hong Kong. The company is also integrating digital technologies and AI, and advancing its ESG practices.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard